title: [Cachexia in cancer patients].
abstract: About 50% of all patients with cancer eventually develop anorexia/cachexia syndrome, which represents a complex clinical syndrome occurring in several illnesses, including cancer. The syndrome is characterized by systemic inflammation and primarily loss of body fat and body mass. In this review we shortly summarize the pathomechanism of anorexia/cachexia syndrome and list the current pharmacological approaches.
authors.affiliation: Egészségügyi Intézményei, Budapest, XV. ker. Önkormányzat, Budapest, Hungary. nagykalnai.tamas@t-online.hu.
authors.forename: Tamás
authors.initials: T
authors.lastname: Nagykálnai
authors.affiliation: Fõvárosi Onkoradiológiai Központ, Uzsoki Utcai Oktató Kórház, Budapest, Hungary.
authors.forename: László
authors.initials: L
authors.lastname: Landherr
mesh_terms: D000855:Anorexia / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D002100:Cachexia / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D006801:Humans; D009369:Neoplasms / Q000150:complications* / Q000188:drug therapy; D013577:Syndrome